Alexion Pharmaceuticals, Inc.

Skandinaviska Enskilda Banken AB (publ) ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/10/2021

Shares

182,821

Value ($000)

33,595

Weight

0.2%

2019 Q4 - 2021 Q2 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/10/2021	33,595	0.2%	182,821	6/30/2021
2021 Q1	5/14/2021	43,915	0.3%	287,266	3/31/2021
2020 Q4	2/11/2021	82,262	0.6%	526,513	12/31/2020
2020 Q3	11/12/2020	44,217	0.3%	386,415	9/30/2020
2020 Q2	8/13/2020	16,231	0.1%	144,611	6/30/2020
2020 Q1	5/13/2020	10,185	0.1%	113,429	3/31/2020
2019 Q4	2/14/2020	13,572	0.1%	125,492	12/31/2019